Based in Shanghai, China, Zou has worked her way up from investment manager since joining LAV in May 2015.
Jieyu Zou has been promoted to managing director at Lilly Asia Ventures (LAV), the venture capital firm spun out of pharmaceutical company Eli Lilly.
Based in Shanghai, China, Zou has worked her way up from investment manager since joining LAV in May 2015.
She is on the boards of Gracell, Transcenta and Virtue DX.
Her earlier deals have included Geneception, CARsgen, Edigene, Tmunity and Passage Bio in new modality therapeutics, Sansure in molecular diagnostics and Avedro, which was acquired in…
